[ALNY] YoY Quarter Result on 30-Jun-2012 [#Q2]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
08-Aug-2012
Financial Year
2012
Quarter
30-Jun-2012 [#Q2]
Profit Trend
QoQ- -13.97%
YoY- 6.28%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Revenue 8,685 7,295 8,687 20,884 20,614 26,617 24,601 -15.92%
PBT -71,352 -44,389 -21,053 -12,956 -13,824 -14,861 -21,794 21.84%
Tax 431 -315 -2,884 -2,855 -1,593 -229 908 -11.67%
NP -71,783 -44,074 -18,169 -12,956 -13,824 -14,632 -22,702 21.14%
Tax Rate - - - - - - - -
Total Cost 80,468 51,369 26,856 33,840 34,438 41,249 47,303 9.25%
Ratio Analysis
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
NP Margin -826.52 -604.17 -209.15 -62.04 -67.06 -54.97 -92.28 44.08%
Per Share
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
EPS -0.85 -0.58 -0.29 -0.25 -0.33 -0.35 -0.55 7.52%
EPS Diluted -0.85 -0.58 -0.29 -0.25 -0.33 -0.35 -0.55 7.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.